Kibria & Sons Pharmaceuticals Private Limited - Company Profile

It is a business services private limited company based in Kanpur, Uttar Pradesh, India, established in 2017.
2017 Kanpur, Uttar Pradesh, India Active
Last Updated:
Access Report
About Kibria & Sons Pharmaceuticals Private Limited

Kibria & Sons Pharmaceuticals Private Limited, a active private limited company, was established on 14 September 2017 in Kanpur, Uttar Pradesh, India. Engaging in miscellaneous business activities within the business services sector, it holds CIN: U74995UP2017PTC096975. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.50 M.

It upholds a compliant status. Its leadership includes Sheeba Hashmi (Director), Faran Hashmi (Director), Shiban Kibria (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 117/K/13 Flat No. 809, Anand Tower, Sarvodaya Nagar,Hansnagar, Kanpur, Uttar Pradesh, 208005.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74995UP2017PTC096975

  • Registration Number

    096975

  • Incorporation Date

    14 September 2017

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 8 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** 3.81%
  • Profit Growth **** -10.46%
  • Ebitda **** 26.90%
  • Net Worth 30.96%
  • Total Assets **** 12.30%
Company report

Kibria & Sons Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Kibria & Sons Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Kibria & Sons Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Sheeba Hashmi Director 14 Sep 2017 Current
Faran Hashmi Director 14 Sep 2017 Current
Shiban Kibria Director 14 Sep 2017 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Kibria & Sons Pharmaceuticals.

Kibria & Sons Pharmaceuticals Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 3.81% increase. The company also saw a substantial fall in profitability, with a 10.46% decrease in profit. The company's net worth Soared by an impressive increase of 30.96%.

Kibria & Sons Pharmaceuticals revenue growth over time
Kibria & Sons Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 3.81%
*******
*******
*******
*******
Revenue from Operations
*******
 3.73%
*******
*******
*******
*******
Total Assets
*******
 12.30%
*******
*******
*******
*******
Profit or Loss
*******
 -10.46%
*******
*******
*******
*******
Net Worth
*******
 30.96%
*******
*******
*******
*******
EBITDA
*******
 26.90%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Kibria & Sons Pharmaceuticals?

Unlock access to Kibria & Sons Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Kibria & Sons Pharmaceuticals?

Unlock and access historical data on people associated with Kibria & Sons Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Kibria & Sons Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kibria & Sons Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Kibria & Sons Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Kibria & Sons Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Kibria & Sons Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur. was documented.

  • Director Appointment

    The activity Sheeba Hashmi was appointed as a Director was appointed as a Director on 14 Sep 2017 & has been associated with this company since 8 years 5 months . was completed.

  • Director Appointment

    The activity Faran Hashmi was appointed as a Director was appointed as a Director on 14 Sep 2017 & has been associated with this company since 8 years 5 months . was completed.

  • Director Appointment

    Progress on Shiban Kibria was appointed as a Director was appointed as a Director on 14 Sep 2017 & has been associated with this company since 8 years 5 months . was documented.

  • Company Incorporation

    Progress on Kibria & Sons Pharmaceuticals Private Limited was registered on 14 Sep 2017 with Roc Kanpur & aged 8 years 5 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Kibria & Sons Pharmaceuticals Private Limited?

The CIN of Kibria & Sons Pharmaceuticals Private Limited is U74995UP2017PTC096975.

Where is Kibria & Sons Pharmaceuticals Private Limited headquartered?

Kibria & Sons Pharmaceuticals Private Limited is headquartered at 117/K/13 Flat No. 809, Anand Tower, Sarvodaya Nagar,Hansnagar, Kanpur, Uttar Pradesh, 208005.

When was Kibria & Sons Pharmaceuticals Private Limited incorporated?

Kibria & Sons Pharmaceuticals Private Limited was incorporated on 14 September 2017.

Who are the current directors of Kibria & Sons Pharmaceuticals Private Limited?

The current directors of Kibria & Sons Pharmaceuticals Private Limited are

What is the primary industry of Kibria & Sons Pharmaceuticals Private Limited?

The primary industry of Kibria & Sons Pharmaceuticals Private Limited is Business Services.

Is Kibria & Sons Pharmaceuticals Private Limited a listed company?

Kibria & Sons Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Kibria & Sons Pharmaceuticals Private Limited?

The authorized capital of Kibria & Sons Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.50 M.

What is the compliance status of Kibria & Sons Pharmaceuticals Private Limited?

The compliance status of Kibria & Sons Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available